Download ALASKA ADJUSTER EXAM FINAL SCRIPT 2026 COMPLETE SOLUTION SET and more Exams Public Policy in PDF only on Docsity!
ALASKA ADJUSTER EXAM FINAL SCRIPT 2026
COMPLETE SOLUTION SET
◉ Pharmacist Applicant Requirement Answer: (1). Be fluent in the reading, writing, and speaking of the English language; (2). Furnish the Board with at least two affidavits from reputable citizens that the applicant has known for at least one year attesting to the applicant's good moral character; (3). Be a graduate of a college in a degree program approved by the Board; (4). Pass an examination or examinations given by the Board or acceptable to the Board under the score transfer process administered by the National Association of Boards of Pharmacy; (5). Have completed internship training or another program that has been approved by the Board, or demonstrated to the Board's satisfaction that the applicant has experience in the practice of pharmacy that meets or exceeds the minimum internship requirements of the Board.
◉ According to Alaska Pharmacy Law, the pharmacist-in-charge of a pharmacy that has changed its name or physical address shall apply for a new and separate pharmacy license. The applicant shall Answer: (1) Submit a new, completed application for a pharmacy license. (2) Pay the duplicate license fee required. (b) Within 14 days after commencement of business under the new license, the pharmacist-in-charge of a pharmacy that has changed its physical address shall complete a self-inspection questionnaire on a form provided by the department. ◉ Rules regarding non-resident pharmacy permit Answer: (1). the location, names, and titles of all principal corporate officers and of all pharmacists who are dispensing prescription drugs to residents of the state; (2). a copy of a current valid license, permit, or registration to conduct operations in the jurisdiction in which it is located, and a copy of the most recent report resulting from an inspection of the pharmacy by the regulatory or licensing agency of the jurisdiction in which the pharmacy is located; (3). a sworn statement indicating that the pharmacy complies with all lawful directions and requests for information from the
Failing to perform any statutory or legal obligation placed upon a licensee. For purposes of this section, failing to repay a student loan issued or guaranteed by the state or the Federal Government in accordance with the terms of the loan or failing to comply with service scholarship obligations shall be considered a failure to perform a statutory or legal obligation, and the minimum disciplinary action imposed shall be a suspension of the license until new payment terms are agreed upon. ◉ When a pharmacy ceases operations, the pharmacist-in-charge of that pharmacy shall: Answer: (1). submit to the board a written notice of the cessation of pharmacy operations; the written notice must be submitted within 10 days (Not 30 days) after the cessation of operations and include: (A). the date the pharmacy ceased operations; (B). a statement signed by the pharmacist-in-charge attesting that an inventory of all controlled substances on hand has been conducted; (C). a statement signed by the pharmacist-in-charge attesting to the manner of disposition for all prescription drugs possessed by the pharmacy;
(2). arrange for the transfer of prescription drug orders or computer prescription records to another pharmacy to facilitate continuous patient care; and (3). provide for the maintenance and availability of prescription drug orders or hard copies of computer prescription records in accordance with 12 AAC 52.450(a) that are not transferred to another pharmacy; (b). In the absence of a pharmacist-in-charge, the owner of the pharmacy shall meet all requirements of this section. ◉ Which of the following should be part of Drug Regimen Review? Answer: 1. Known allergies;
- Rational therapy-contraindications;
- Reasonable dose and route of administration;
- Reasonable directions for use;
- Duplication of therapy;
statement from the applicant attesting to the applicant's fluency in reading, writing, and speaking the English language; (2). the applicable fees established in 12 AAC 02.310; (3). on a form provided by the department, a signed authorization for the release of records relating to the applicant's qualifications for licensure; (4). either (A). an official transcript, sent directly to the department from the applicant's college of pharmacy, that establishes that the applicant has received a professional degree from a college of pharmacy accredited by the ACPE; or (B). a certified copy of (i) the original pharmacy school diploma issued to the applicant; and (ii) a Foreign Pharmacy Graduate Examination Committee certificate issued to the applicant by the National Association of Boards of Pharmacy, sent directly to the department from the National Association of Boards of Pharmacy; (5). two affidavits from reputable citizens that the applicant has known for at least one year attesting to the applicant's good moral character;
(6). verification that the applicant has completed 1,500 hours of internship or experience in the practice of pharmacy that meet the requirements of 12 AAC 52.080, sent directly to the department from the agency where the hours of internship or experience were completed; (7). verification that the applicant has passed the examinations required in 12 AAC 52.090, sent directly to the department by the National Association of Boards of Pharmacy. ◉ According to Alaska State Pharmacy Law, the prescription record should be kept for: Answer: 2 years from date of dispensing ◉ Issuing temporary pharmacist liscense Answer: (1). submits a completed application for licensure; (2). provides certified evidence of meeting the requirements in Alaska Pharmacy Law; (3). provides for the National Association of Boards of Pharmacy (NABP) to notify the board that the applicant has submitted a preliminary application to NABP for license transfer; (4). pays the application fee, pharmacist license fee, and temporary license fee;
◉ An emergency pharmacy permit is valid for 60 days or until the emergency circumstances no longer exist, whichever is shorter. Answer: (a). If the board determines that an emergency exists, the board will issue an emergency pharmacist permit for the purpose of providing coverage in a pharmacy that is temporarily without the services of a pharmacist due to death, illness, or other emergency circumstances, to an applicant who: (1). submits a completed application for a pharmacist license; (2). pays the emergency permit fee required in 12 AAC 02.310; (3). submits a certified true copy of a current pharmacist license in good standing in another state; (4). passes the Alaska pharmacy jurisprudence examination with a scaled score of 75 or above; and (5). has not been convicted of a felony or another crime that affects the applicant's ability to practice pharmacy competently and safely. (b). An emergency permit is valid for 60 days or until the emergency circumstances no longer exist, whichever is shorter.
(c). An applicant may not receive more than one emergency permit. An emergency permit is not renewable. ◉ The following checklist is established by the board for review by staff of an application for an out-of-state pharmacy registration. An out-of-state pharmacy registration will be issued to an applicant who: Answer: (1). applies on an application provided by the department that includes: (A). the company name and owner name; (B). the pharmacy name; (C). the location of the facility; (D). a mailing address and telephone number; (E). a toll free number accessible by patients in this state; (F). the federal employer identification number; (G). the names of all partners or corporate officers;
12 - month period to individual patients in the state shall register with the board. ◉ A pharmacist receives a new prescription from a prescriber for compounding a cream that is commercially available. What shall pharmacist do? Answer: Compounding a drug product that is commercially available in the marketplace or that is essentially a copy of a commercially available FDA-approved drug product is generally prohibited. However, in special circumstances a pharmacist may compound an appropriate quantity of a drug that is only slightly different than an FDA-approved drug that is commercially available based on documentation provided by the prescribing physician of a patient specific medical need (e.g. the physician requests an alternate product due to hypersensitivity to excipients or preservative in the FDA-approved product, or the physician requests an effective alternate dosage form) or if the drug product is not commercially available. The unavailability of such drug product must be documented prior to compounding. ◉ Duties can be only performed by pharmacist Answer: (1). receiving an oral prescription drug order, including refill approval or denial that includes any change to the original prescription drug order;
(2). consulting with a prescriber regarding a patient or prescription; (3). interpreting a prescription drug order; (4). determining the product required for a prescription; (5). interpreting data in a patient medication record system; (6). making a final check on all aspects of a completed prescription and assuming the responsibility for a filled prescription, including the accuracy of the drug prescribed and of the prescribed drug's strength, labeling, and proper container; and (7). consulting with a patient or a patient's agent regarding a prescription or information contained in the patient medication record system. 12 AAC 52.220: (a). A pharmacist intern may not represent that the pharmacist intern is a pharmacist. Only a person licensed by the board as a pharmacist intern may take, use, or exhibit the title of pharmacist intern or any other similar term.
◉ The pharmacy engagement in which of the following acts may consider by the FDA the violation of the new drug, adulteration, or misbranding provisions of the Act? Answer: 1. Compounding of drugs in anticipation of receiving prescriptions, except in very limited quantities in relation to the amounts of drugs compounded after receiving valid prescriptions. Compounding very large quantities of particular drug before receiving valid prescriptions is considered as manufacturing.
- Compounding drugs that were withdrawn or removed from the market for safety reasons. Appendix A provides a list of such drugs that will be updated in the future, as appropriate.
- Compounding finished drugs from bulk active ingredients that are not components of FDA approved drugs without an FDA sanctioned investigational new drug application (IND) in accordance with 21 U.S.C. § 355(i) and 21 CFR 312.
- Receiving, storing, or using drug substances without first obtaining written assurance from the supplier that each lot of the drug substance has been made in an FDA-registered facility.
- Receiving, storing, or using drug components not guaranteed or otherwise determined to meet official compendia requirements.
- Using commercial scale manufacturing or testing equipment for compounding drug products.
- Compounding drugs for third parties who resell to individual patients or offering compounded drug products at wholesale to other state licensed persons or commercial entities for resale.
- Compounding drug products that are commercially available in the marketplace or that are essentially copies of commercially available FDA-approved drug products. In certain circumstances, it may be appropriate for a pharmacist to compound a small quantity of a drug that is only slightly different than an FDA-approved drug that is commercially available. In these circumstances, FDA will consider whether there is documentation of the medical need for the particular variation of the compound for the particular patient ◉ In Alaska, a pharmacist should not dispense any non-controlled drug or device if the prescription is presented: Answer: More than 365 days after the date of issuance,
- An officer elected by the Board serves a term of one year and may not serve more than four consecutive full terms in a specific office ◉ Who may enter and inspect a permit holder's pharmacy during normal business hours? Answer: Only peace officer According to Alaska State Pharmacy Law, a peace officer may enter a registrant's premises at reasonable times and in a reasonable manner to inspect the premises and records required to be maintained under federal law. An inspection may not extend to financial data, pricing data, or sales data, other than shipment data, unless the owner, operator, or agent in charge of the premises consents. ◉ How many contact hours of continuing education are required by an applicant for renewing a pharmacy technician license? Answer: 10 hours (a). Except as provided in (c) of this section, an applicant for renewal of a pharmacy technician license shall certify that, during the concluding licensing period, the applicant (1). completed 10 contact hours of continuing education accepted by the board under 12 AAC 52.340; OR
(2). obtained initial certification as a pharmacy technician by the Pharmacy Technician Certification Board (PTCB). (b). This section does not prevent the board from imposing additional continuing education requirements under its disciplinary powers. (c). Instead of complying with the continuing education requirements in (a) of this section, an applicant for renewal of a pharmacy technician license for the first time may (1). verify in an affidavit, on an application for renewal, that the applicant has read the state statutes and regulations compiled by the board; and (2). submit an affidavit, signed by the pharmacist-in-charge, verifying the applicant's pharmacy technician training in accordance with 12 AAC 52.230. (d). An applicant for reinstatement of a pharmacy technician license that has expired shall certify that the applicant completed the continuing education requirements in (a) of this section before applying for reinstatement.
